{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:51:44Z","timestamp":1771876304988,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,8,18]],"date-time":"2006-08-18T00:00:00Z","timestamp":1155859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s10038-006-0025-1","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T10:59:29Z","timestamp":1155812369000},"page":"822-826","source":"Crossref","is-referenced-by-count":62,"title":["Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy"],"prefix":"10.1038","volume":"51","author":[{"given":"Hiroshi","family":"Takane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Burioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Shigemasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ieiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,18]]},"reference":[{"key":"25_CR1","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1001\/jama.291.23.2821","volume":"291","author":"DI Chasman","year":"2004","unstructured":"Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP, Ridker PM (2004) Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 291:2821\u20132827","journal-title":"JAMA"},{"key":"25_CR2","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1074\/jbc.272.6.3444","volume":"272","author":"AD Cooper","year":"1997","unstructured":"Cooper AD, Chen J, Botelho-Yetkinler MJ, Cao Y, Taniguchi T, Levy-Wilson B (1997) Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7alpha-hydroxylase gene. J Biol Chem 272:3444\u20133452","journal-title":"J Biol Chem"},{"key":"25_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","volume":"31","author":"JE Hixon","year":"1990","unstructured":"Hixon JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545\u2013548","journal-title":"J Lipid Res"},{"key":"25_CR4","doi-asserted-by":"publisher","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","volume":"274","author":"B Hsiang","year":"1999","unstructured":"Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG (1999) A novel human hepatic organic anion transporting polypeptide (OATP2). J Biol Chem 274:37161\u201337168","journal-title":"J Biol Chem"},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0009-9120(03)00025-0","volume":"36","author":"JA Hubacek","year":"2003","unstructured":"Hubacek JA, Pitha J, Skodova Z, Poledne R, Lanska V, Waterworth DM, Humphries SE, Talmud PJ (2003) Czech MONICA Study. Polymorphisms in CYP7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8\u00a0year follow-up; results from the Czech MONICA study. Clin Biochem 36:263\u2013267","journal-title":"Clin Biochem"},{"key":"25_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1124\/dmd.30.4.363","volume":"30","author":"M Itoda","year":"2002","unstructured":"Itoda M, Saito Y, Soyama A, Saeki M, Murayama N, Ishida S, Sai K, Nagano M, Suzuki H, Sugiyama Y, Ozawa S, Sawada J (2002) Polymorphisms in the ABCC2 (cMOAT\/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5\u2019-untranslated region and exon 28. Drug Metab Dispos 30:363\u2013364","journal-title":"Drug Metab Dispos"},{"key":"25_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/00008571-200411000-00006","volume":"14","author":"M Iwai","year":"2004","unstructured":"Iwai M, Suzuki H, Ieiri I, Otsubo K, Sugiyama Y (2004) Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C). Pharmacogenetics 14:749\u2013757","journal-title":"Pharmacogenetics"},{"key":"25_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1194\/jlr.M300278-JLR200","volume":"45","author":"K Kajinami","year":"2004","unstructured":"Kajinami K, Brousseau ME, Nartsupha C, Ordovas JM, Schaefer EJ (2004) ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J Lipid Res 45:653\u2013656","journal-title":"J Lipid Res"},{"key":"25_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.atherosclerosis.2004.12.019","volume":"180","author":"K Kajinami","year":"2005","unstructured":"Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ (2005) A promoter polymorphism in cholesterol 7\u03b1 a-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. Atherosclerosis 180:407\u2013415","journal-title":"Atherosclerosis"},{"key":"25_CR10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1124\/jpet.105.085589","volume":"314","author":"S Matsushima","year":"2005","unstructured":"Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, Sugiyama Y (2005) Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)\/multidrug resistance-associated protein 2, OATP1B1\/multidrug resistance 1, and OATP1B1\/breast cancer resistance protein. J Pharmacol Exp Ther 314:1059\u20131067","journal-title":"J Pharmacol Exp Ther"},{"key":"25_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/01213011-200505000-00005","volume":"15","author":"M Niemi","year":"2005","unstructured":"Niemi M, Neuvonen PJ, Hofmann U, Backman JT, Schwab M, Lutjohann D, von Bergmann K, Eichelbaum M, Kivisto KT (2005) Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype*17. Pharmacogenet Genomics 15:303\u2013309","journal-title":"Pharmacogenet Genomics"},{"key":"25_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0009-9236(03)00060-2","volume":"73","author":"Y Nishizato","year":"2003","unstructured":"Nishizato Y Nishizato, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y (2003) Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 73:554\u2013565","journal-title":"Clin Pharmacol Ther"},{"key":"25_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2796.1991.tb00464.x","volume":"230","author":"JP Ojala","year":"1991","unstructured":"Ojala JP, Helve E, Ehnholm C, Aalto-Setala K, Kontula KK, Tikkanen MJ (1991) Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia. J Intern Med 230:397\u2013405","journal-title":"J Intern Med"},{"key":"25_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0021-9150(94)05439-P","volume":"113","author":"JM Ordovas","year":"1995","unstructured":"Ordovas JM, Lopez-Miranda J, Perez-Jimenez F, Rodriguez C, Park JS, Cole T, Schaefer EJ (1995) Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein HMG CoA reductase inhibitor therapy. Atherosclerosis 113:157\u2013166","journal-title":"Atherosclerosis"},{"key":"25_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0021-9150(95)05571-D","volume":"117","author":"F Pazzucconi","year":"1995","unstructured":"Pazzucconi F, Dorigotti F, Gianfranceschi G, Campagnoli G, Sirtori M, Franceschini G, Sirtori CR (1995) Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity. Atherosclerosis 117:189\u2013198","journal-title":"Atherosclerosis"},{"key":"25_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","volume":"110","author":"CR Pullinger","year":"2002","unstructured":"Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP (2002) Human cholesterol 7\u03b1-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109\u2013117","journal-title":"J Clin Invest"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg2006126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2006126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2006126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T19:35:02Z","timestamp":1638387302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg2006126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,18]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s10038-006-0025-1","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,18]]}}}